Brace Pharma Capital is a strategic investment firm based in Atlanta, focused on innovative therapies for diseases with significant unmet medical needs. It was formed by EMS S/A and high-net-worth biotech investors.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Brace Pharma Capital is a strategic investment company founded in 2012, formed by EMS S/A, Brazil's largest pharmaceutical company, and high-net-worth biotech investors. The firm specializes in investing in innovative therapies targeting diseases with high unmet medical needs and insufficient treatment options. Brace Pharma Capital aims to support biotech and pharmaceutical companies with clinical or validated pre-clinical assets, focusing on projects that can reach the market within defined regulatory timelines. Its investment criteria prioritize clinical-stage projects and those with predictive animal models, emphasizing technical and regulatory success probabilities.
Brace Pharma Capital invests in innovative therapies targeting diseases with significant unmet medical needs. The firm prioritizes clinical-stage projects with the potential to reach the market in 3-5 years and pre-clinical projects with predictive animal models that can reach the market in 5-7 years.
Brace Pharma Capital adds value to its portfolio companies by leveraging its expertise in clinical and regulatory affairs, providing strategic guidance, and facilitating connections within the biopharma industry. The firm focuses on projects with strong management teams and a clear path to market, ensuring that its investments are well-positioned for success.
Brace Pharma Capital focuses on innovative therapies that address significant unmet medical needs, particularly in the biotech and pharmaceutical sectors. They seek companies developing life-changing treatments.
Founders can reach out via email at info@bracepharma.com. A well-prepared pitch deck that outlines the innovation, market need, and team background is recommended.
The firm is uniquely positioned due to its backing by EMS S/A, Brazil's largest pharmaceutical company, which provides extensive industry knowledge and resources.
Brace Pharma Capital invests globally, focusing on biotech and healthcare companies that are developing innovative therapies.
While specific check sizes are not disclosed, Brace Pharma Capital typically invests in early to growth-stage companies, providing the necessary capital to advance their development.
Brace Pharma Capital offers operational support, strategic guidance, and access to a network of industry experts to help portfolio companies succeed.
Organizations that do similar work to Brace Pharma Capital.
InvestorF-Prime Capital is a venture capital firm based in Cambridge, Massachusetts, with additional offices in London and San Francisco. It focuses on investments in life sciences, technology, healthtech, and crypto, managing approximately $4.8 billion in assets.
InvestorSV Health Investors is a healthcare-focused venture capital and growth equity firm based in Boston and London. With over 30 years of experience, it specializes in investing across various healthcare sectors, including biotechnology and medtech.
InvestorPaladin Capital Group is a multi-stage venture capital firm based in Washington, D.C., investing in innovative technology across sectors like cybersecurity and artificial intelligence. They have a global presence with offices in major cities.
InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.
Superscout Pro
Is this page right?Reviewed · How the research works